220 related articles for article (PubMed ID: 34292797)
21. The role of hysteroscopy in fertility preservation in endometrial cancer and atypical endometrial hyperplasia: a semi-systematic literature review.
Bilir E; Kahramanoğlu İ
Arch Gynecol Obstet; 2023 Oct; 308(4):1113-1126. PubMed ID: 36807742
[TBL] [Abstract][Full Text] [Related]
22. A survey of French gynecologists' knowledge and attitudes toward conservative treatment for fertility preservation in young patients with endometrial cancer.
Peigné M; Maumy L; Koskas M
J Gynecol Obstet Hum Reprod; 2020 Sep; 49(7):101794. PubMed ID: 32416273
[TBL] [Abstract][Full Text] [Related]
23. Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer.
Yang B; Xu Y; Zhu Q; Xie L; Shan W; Ning C; Xie B; Shi Y; Luo X; Zhang H; Chen X
Gynecol Oncol; 2019 Apr; 153(1):55-62. PubMed ID: 30674421
[TBL] [Abstract][Full Text] [Related]
24. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
Hurst SA; Hartzfeld KM; Del Priore G
Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
[TBL] [Abstract][Full Text] [Related]
25. Fertility-Sparing Treatment of Endometrial Cancer with Initial Infiltration of Myometrium by Resectoscopic Surgery: A Pilot Study.
Casadio P; Guasina F; Paradisi R; Leggieri C; Caprara G; Seracchioli R
Oncologist; 2018 Apr; 23(4):478-480. PubMed ID: 29317550
[TBL] [Abstract][Full Text] [Related]
26. Hysteroscopic treatments for endometrial malignancies and premalignancies: state of the art.
Kahramanoglu I
Minim Invasive Ther Allied Technol; 2021 Oct; 30(5):272-277. PubMed ID: 34289318
[TBL] [Abstract][Full Text] [Related]
27. Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer.
Park JY; Nam JH
Oncologist; 2015 Mar; 20(3):270-8. PubMed ID: 25673106
[TBL] [Abstract][Full Text] [Related]
28. Conservative Surgery in Endometrial Cancer.
Gallo A; Catena U; Saccone G; Di Spiezio Sardo A
J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011924
[TBL] [Abstract][Full Text] [Related]
29. Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions.
Contreras NA; Sabadell J; Verdaguer P; Julià C; Fernández-Montolí ME
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269674
[TBL] [Abstract][Full Text] [Related]
30. Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women.
Uccella S; Zorzato PC; Dababou S; Bosco M; Torella M; Braga A; Frigerio M; Gardella B; Cianci S; Laganà AS; Franchi MP; Garzon S
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143933
[TBL] [Abstract][Full Text] [Related]
31. Fertility preserving treatment for gynecologic malignancies: a review of recent literature.
Coakley K; Wolford J; Tewari KS
Curr Opin Obstet Gynecol; 2020 Feb; 32(1):51-56. PubMed ID: 31851046
[TBL] [Abstract][Full Text] [Related]
32. Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1-2 with superficial myometrial invasion: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-2001).
Lee AJ; Yang EJ; Kim NK; Kim Y; Suh DH; Kim J; Son JH; Kong TW; Chang SJ; Hwang DW; Park SJ; Kim HS; Yoo JG; Lee SJ; Lee YY; Shim SH
Gynecol Oncol; 2023 Jul; 174():106-113. PubMed ID: 37172410
[TBL] [Abstract][Full Text] [Related]
33. Fertility-sparing management for endometrial cancer: review of the literature.
Garzon S; Uccella S; Zorzato PC; Bosco M; Franchi MP; Student V; Mariani A
Minerva Med; 2021 Feb; 112(1):55-69. PubMed ID: 33205638
[TBL] [Abstract][Full Text] [Related]
34. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE
Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246
[TBL] [Abstract][Full Text] [Related]
35. Management of women with atypical polypoid adenomyoma of the uterus: A quantitative systematic review.
Raffone A; Travaglino A; Saccone G; Alviggi C; Mascolo M; De Placido G; Insabato L; Mollo A; Zullo F
Acta Obstet Gynecol Scand; 2019 Jul; 98(7):842-855. PubMed ID: 30714089
[TBL] [Abstract][Full Text] [Related]
36. [Atypical polypoid adenomyoma of the uterus: a clinicopathological review of 27 cases].
Bai TJ; Bao DM; Li Y; Wang Y; Cui H; Zhu HL
Zhonghua Fu Chan Ke Za Zhi; 2017 Apr; 52(4):244-248. PubMed ID: 28441840
[No Abstract] [Full Text] [Related]
37. Fertility-sparing treatment in early endometrial cancer: current state and future strategies.
Obermair A; Baxter E; Brennan DJ; McAlpine JN; Muellerer JJ; Amant F; van Gent MDJM; Coleman RL; Westin SN; Yates MS; Krakstad C; Janda M
Obstet Gynecol Sci; 2020 Jul; 63(4):417-431. PubMed ID: 32689770
[TBL] [Abstract][Full Text] [Related]
38. Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer.
Gonthier C; Walker F; Luton D; Yazbeck C; Madelenat P; Koskas M
Gynecol Oncol; 2014 Apr; 133(1):33-7. PubMed ID: 24680589
[TBL] [Abstract][Full Text] [Related]
39. Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.
Chung YS; Woo HY; Lee JY; Park E; Nam EJ; Kim S; Kim SW; Kim YT
Am J Obstet Gynecol; 2021 Apr; 224(4):370.e1-370.e13. PubMed ID: 33039397
[TBL] [Abstract][Full Text] [Related]
40. Conservative treatment of early endometrial cancer: preliminary results of a pilot study.
Laurelli G; Di Vagno G; Scaffa C; Losito S; Del Giudice M; Greggi S
Gynecol Oncol; 2011 Jan; 120(1):43-6. PubMed ID: 21040953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
